91Ó°ÊÓ

In hypothesis testing, the null hypothesis serves as a starting assumption that there is no effect or difference between groups or variables being studied. This is what researchers aim to test against.
In the context of the provided exercise, the null hypothesis (\( H_0 \)) suggests that the proportion of bad outcomes (i.e., recurrence of a blood clot in a vein) among patients using standard therapy is the same as the proportion among those using the new rivaroxaban therapy.
Formally, this can be represented as \( p_1 = p_2 \), where \( p_1 \) and \( p_2 \) are the population proportions of adverse results in the standard and rivaroxaban groups, respectively. By creating a null hypothesis, researchers set a baseline that allows them to use statistical methods to determine if there is sufficient evidence to indicate a difference between the groups.

Contrary to the null hypothesis, the alternative hypothesis proposes there is a difference between the groups being studied. It is formulated when researchers suspect that certain factors do not behave similarly for the groups.
In the exercise, the alternative hypothesis (\( H_a \)) posits that the proportions of adverse outcomes are different between the standard therapy and rivaroxaban groups.
This is expressed as \( p_1 eq p_2 \).
The alternative hypothesis is an essential part of hypothesis testing as it opens up an avenue for exploring new and significant findings. By comparing the null and alternative hypotheses, we can determine whether to reject the null hypothesis based on the statistical evidence.

The Z-test for two proportions is a statistical method used to compare the proportions of two independent groups and determine if they are significantly different from each other. This test is especially useful when dealing with large samples.
To perform a Z-test for two proportions, the first step is to calculate the pooled proportion, \( \hat{p} \), which is the combined proportion of adverse outcomes from both the standard therapy and rivaroxaban groups. This is computed using the formula: \[ \hat{p} = \frac{x_1 + x_2}{n_1 + n_2} \] where \( x_1 \) and \( x_2 \) are the number of adverse outcomes, and \( n_1 \) and \( n_2 \) are the total number of patients in each group.
Next, calculate the test statistic represented by the Z value: \[ Z = \frac{\hat{p_1} - \hat{p_2}}{\sqrt{\hat{p}(1-\hat{p})(\frac{1}{n_1} + \frac{1}{n_2})}} \] where \( \hat{p_1} \) and \( \hat{p_2} \) are the sample proportions for the standard and rivaroxaban therapy groups. The Z-test helps in determining whether to reject the null hypothesis by comparing the calculated Z-score with a critical value corresponding to the chosen significance level.

A confidence interval provides a range of values which estimates the difference in population proportions, giving insight into where the true difference lies.
In this exercise, a 95% confidence interval is computed for the difference in proportions of bad outcomes between the two therapies. The confidence interval is calculated using: \[ (\hat{p_1} - \hat{p_2}) \pm Z_{1-\alpha/2} \sqrt{\frac{\hat{p_1}(1-\hat{p_1})}{n_1} +\frac{\hat{p_2}(1-\hat{p_2})}{n_2}} \] where \( Z_{1- \alpha/2} \) corresponds to the Z-score that cuts off the top \( \alpha/2 \) area in the standard normal distribution for a 95% confidence level.
This interval provides a range within which the difference between the two population proportions is likely to lie, with a certain level of confidence. If the confidence interval does not contain zero, it implies that there is a statistically significant difference between the groups, allowing us to reject the null hypothesis and accept the alternative hypothesis.